Do analysts prefer DRTSW or SINT?

Sintx Technologies has a consensus target price of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Alpha Tau Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has higher valuation and earnings, DRTSW or SINT?

Alpha Tau Medical has higher earnings, but lower revenue than Sintx Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Tau Medical N/A N/A N/A N/A N/A Sintx Technologies $1.02M 9.36 -$10.36M -$4.91 N/A

Do analysts prefer SINT or BDMDW?

Sintx Technologies currently has a consensus price target of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, SINT or BDMDW?

Baird Medical Investment has higher revenue and earnings than Sintx Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sintx Technologies $1.02M 9.36 -$10.36M -$4.91 N/A Baird Medical Investment $24.49M N/A N/A N/A N/A

Do analysts prefer COCHW or SINT?

Sintx Technologies has a consensus target price of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Envoy Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has stronger valuation & earnings, COCHW or SINT?

Envoy Medical has higher earnings, but lower revenue than Sintx Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envoy Medical $207K N/A N/A N/A N/A Sintx Technologies $1.02M 9.36 -$10.36M -$4.91 N/A

Does the media prefer COCHW or SINT?

In the previous week, Sintx Technologies had 8 more articles in the media than Envoy Medical. MarketBeat recorded 9 mentions for Sintx Technologies and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.11 indicating that Envoy Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer HSCSW or SINT?

Sintx Technologies has a consensus price target of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Heart Test Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better earnings & valuation, HSCSW or SINT?

Heart Test Laboratories has higher earnings, but lower revenue than Sintx Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heart Test Laboratories $4.52K N/A N/A N/A N/A Sintx Technologies $1.02M 9.36 -$10.36M -$4.91 N/A

Do analysts rate BEATW or SINT?

Sintx Technologies has a consensus price target of $9.50, indicating a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than HeartBeam. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartBeam 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has higher earnings and valuation, BEATW or SINT?

HeartBeam has higher earnings, but lower revenue than Sintx Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HeartBeam N/A N/A N/A N/A N/A Sintx Technologies $1.02M 9.36 -$10.36M -$4.91 N/A

Sintx Technologies (SINT) Competitors

$2.21 +0.08 (+3.76%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$2.16 -0.05 (-2.44%)

As of 10/2/2026 07:07 PM Eastern

Compare

SINT vs. DRTSW, BDMDW, COCHW, HSCSW, and BEATW

Should you buy Sintx Technologies stock or one of its competitors? Sintx Technologies's main competitors and comparable companies include Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sintx Technologies compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Sintx Technologies has a consensus target price of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Sintx Technologies had 9 more articles in the media than Alpha Tau Medical. MarketBeat recorded 9 mentions for Sintx Technologies and 0 mentions for Alpha Tau Medical. Sintx Technologies' average media sentiment score of 0.11 beat Alpha Tau Medical's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Tau Medical	Neutral
Sintx Technologies	Neutral

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Alpha Tau Medical has higher earnings, but lower revenue than Sintx Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
Sintx Technologies	$1.02M	9.36	-$10.36M	-$4.91	N/A

Alpha Tau Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Alpha Tau Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	N/A	N/A
Sintx Technologies	-848.20%	-354.44%	-115.37%

Summary

Sintx Technologies beats Alpha Tau Medical on 8 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to Baird Medical Investment?

Sintx Technologies (NASDAQ:SINT) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

Sintx Technologies currently has a consensus price target of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Baird Medical Investment	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Baird Medical Investment has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Baird Medical Investment's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Baird Medical Investment	N/A	N/A	N/A

In the previous week, Sintx Technologies had 9 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Sintx Technologies and 0 mentions for Baird Medical Investment. Sintx Technologies' average media sentiment score of 0.11 beat Baird Medical Investment's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Sintx Technologies	Neutral
Baird Medical Investment	Neutral

Baird Medical Investment has higher revenue and earnings than Sintx Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	9.36	-$10.36M	-$4.91	N/A
Baird Medical Investment	$24.49M	N/A	N/A	N/A	N/A

Summary

Sintx Technologies beats Baird Medical Investment on 7 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to Envoy Medical?

Envoy Medical (NASDAQ:COCHW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Envoy Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Envoy Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	N/A
Sintx Technologies	-848.20%	-354.44%	-115.37%

In the previous week, Sintx Technologies had 8 more articles in the media than Envoy Medical. MarketBeat recorded 9 mentions for Sintx Technologies and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.11 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envoy Medical has higher earnings, but lower revenue than Sintx Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$207K	N/A	N/A	N/A	N/A
Sintx Technologies	$1.02M	9.36	-$10.36M	-$4.91	N/A

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sintx Technologies has a consensus target price of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Sintx Technologies beats Envoy Medical on 7 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

In the previous week, Sintx Technologies had 9 more articles in the media than Heart Test Laboratories. MarketBeat recorded 9 mentions for Sintx Technologies and 0 mentions for Heart Test Laboratories. Sintx Technologies' average media sentiment score of 0.11 beat Heart Test Laboratories' score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Heart Test Laboratories	Neutral
Sintx Technologies	Neutral

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sintx Technologies has a consensus price target of $9.50, suggesting a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Heart Test Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Heart Test Laboratories has higher earnings, but lower revenue than Sintx Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$4.52K	N/A	N/A	N/A	N/A
Sintx Technologies	$1.02M	9.36	-$10.36M	-$4.91	N/A

Heart Test Laboratories has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Heart Test Laboratories' return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	N/A	N/A
Sintx Technologies	-848.20%	-354.44%	-115.37%

Summary

Sintx Technologies beats Heart Test Laboratories on 8 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to HeartBeam?

HeartBeam (NASDAQ:BEATW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

In the previous week, Sintx Technologies had 9 more articles in the media than HeartBeam. MarketBeat recorded 9 mentions for Sintx Technologies and 0 mentions for HeartBeam. Sintx Technologies' average media sentiment score of 0.11 beat HeartBeam's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
HeartBeam	Neutral
Sintx Technologies	Neutral

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

HeartBeam has higher earnings, but lower revenue than Sintx Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartBeam	N/A	N/A	N/A	N/A	N/A
Sintx Technologies	$1.02M	9.36	-$10.36M	-$4.91	N/A

HeartBeam has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. HeartBeam's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartBeam	N/A	N/A	N/A
Sintx Technologies	-848.20%	-354.44%	-115.37%

Sintx Technologies has a consensus price target of $9.50, indicating a potential upside of 329.86%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than HeartBeam.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartBeam	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Sintx Technologies beats HeartBeam on 8 of the 11 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SINT vs. The Competition

Export

Metric	Sintx Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$5.48B	$7.16B	$13.28B
Dividend Yield	N/A	1.81%	2.54%	17.32%
P/E Ratio	-0.45	24.90	275.66	26.04
Price / Sales	9.36	67.76	608.92	91.72
Price / Cash	N/A	32.27	78.87	52.62
Price / Book	2.76	5.73	10.93	6.31
Net Income	-$10.36M	$152.68M	$3.51B	$362.16M
7 Day Performance	17.55%	-1.71%	-2.00%	-1.66%
1 Month Performance	35.58%	-4.87%	-6.19%	-4.68%
1 Year Performance	-43.91%	1.30%	8.03%	1.57%

Sintx Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SINT Sintx Technologies	3.1411 of 5 stars	$2.21 +3.8%	$9.50 +329.9%	-43.9%	$0.00	$1.02M	N/A	32	News Coverage Analyst Forecast Short Interest Decrease High Trading Volume
DRTSW Alpha Tau Medical	N/A	$4.18 +2.0%	N/A	+983.6%	$0.00	N/A	N/A	121	Positive News
BDMDW Baird Medical Investment	N/A	$0.03 flat	N/A	N/A	$0.00	$24.49M	N/A	146	Gap Up
COCHW Envoy Medical	N/A	$0.03 +16.3%	N/A	+7.1%	$0.00	$207K	N/A	47	Positive News Gap Up High Trading Volume
HSCSW Heart Test Laboratories	N/A	$0.07 +64.8%	N/A	-28.7%	$0.00	$4.52K	N/A	14	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SINT) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sintx Technologies (SINT) Competitors

SINT vs. DRTSW, BDMDW, COCHW, HSCSW, and BEATW

How does Sintx Technologies compare to Alpha Tau Medical?

Summary

How does Sintx Technologies compare to Baird Medical Investment?

Summary

How does Sintx Technologies compare to Envoy Medical?

Summary

How does Sintx Technologies compare to Heart Test Laboratories?

Summary

How does Sintx Technologies compare to HeartBeam?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sintx Technologies (SINT) Competitors

SINT vs. DRTSW, BDMDW, COCHW, HSCSW, and BEATW

How does Sintx Technologies compare to Alpha Tau Medical?

Do analysts prefer DRTSW or SINT?

Does the media favor DRTSW or SINT?

Do institutionals and insiders have more ownership in DRTSW or SINT?

Which has higher valuation and earnings, DRTSW or SINT?

Is DRTSW or SINT more profitable?

Summary

How does Sintx Technologies compare to Baird Medical Investment?

Do analysts prefer SINT or BDMDW?

Is SINT or BDMDW more profitable?

Do insiders and institutionals hold more shares of SINT or BDMDW?

Does the media refer more to SINT or BDMDW?

Which has better earnings & valuation, SINT or BDMDW?

Summary

How does Sintx Technologies compare to Envoy Medical?

Is COCHW or SINT more profitable?

Does the media prefer COCHW or SINT?

Which has stronger valuation & earnings, COCHW or SINT?

Do insiders & institutionals have more ownership in COCHW or SINT?

Do analysts prefer COCHW or SINT?

Summary

How does Sintx Technologies compare to Heart Test Laboratories?

Does the media prefer HSCSW or SINT?

Do insiders & institutionals have more ownership in HSCSW or SINT?

Do analysts prefer HSCSW or SINT?

Which has better earnings & valuation, HSCSW or SINT?

Is HSCSW or SINT more profitable?

Summary

How does Sintx Technologies compare to HeartBeam?

Does the media favor BEATW or SINT?

Do institutionals & insiders hold more shares of BEATW or SINT?

Which has higher earnings and valuation, BEATW or SINT?

Is BEATW or SINT more profitable?

Do analysts rate BEATW or SINT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools